Tag Archives: Hepatic encephalopathy

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic encephalopathy is a brain dysfunction involving neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting with a severity that ranges from minor symptoms to coma. There have been reported differences in gut microbiota between those with and without hepatic encephalopathy. A previous Cochrane systematic review including 38 randomised clinical trials on non-absorbable disaccharides (lactulose and lactitol) versus…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.